Supersonic Imagine Stock: price and insider trades · France
No insider purchase over the last 90 days. The latest, by Michelangelo Stefani, was filed 08 Dec 2021.
Supersonic Imagine: what insiders have been doing
Supersonic Imagine is a Healthcare & Pharma company. Its directors and officers file their transactions with AMF. The past year has been quiet: not a single insider filing for Supersonic Imagine. The previous disclosure was published on 8 December 2021.
Since 2021, the database holds 12 purchases and no sales by insiders of the company.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. Source: insider filings from AMF. Past trades are no guide to future returns.
Financial data
· cache
- 62,461 shares@ €1.501.7% of flowActionEuronext Growth ParisISIN FR00105268142021DD745177Canonical exit: 26 Jul 2021 (T+90)
- 2,454,159 shares@ €1.5067.1% of flowActionEuronext Growth ParisISIN FR00105268142021DD745176Canonical exit: 3 Aug 2021 (T+90)
- 38,562 shares@ €1.501.1% of flowActionEuronext Growth ParisISIN FR00105268142021DD744166Canonical exit: 29 Jul 2021 (T+90)
- 16,236 shares@ €1.500.4% of flowActionEuronext Growth ParisISIN FR00105268142021DD743438Canonical exit: 27 Jul 2021 (T+90)
- 543,921 shares@ €1.5014.9% of flowActionEuronext Growth ParisISIN FR00105268142021DD742878Canonical exit: 25 Jul 2021 (T+90)
- 191,900 shares@ €1.505.2% of flowActionEuronext Growth ParisISIN FR00105268142021DD742660Canonical exit: 22 Jul 2021 (T+90)
- 128,330 shares@ €1.503.5% of flowActionEuronext Growth ParisISIN FR00105268142021DD742436Canonical exit: 21 Jul 2021 (T+90)
- 6,316 shares@ €1.50100.0% of flowActionEuronext Growth ParisISIN FR00105268142021DD742200Canonical exit: 20 Jul 2021 (T+90)
- 5,519 shares@ €1.500.2% of flowActionEuronext Growth ParisISIN FR00105268142021DD741968Canonical exit: 19 Jul 2021 (T+90)
- 18,500 shares@ €1.500.5% of flowActionEuronext Growth ParisISIN FR00105268142021DD741748Canonical exit: 18 Jul 2021 (T+90)
- 53,490 shares@ €1.501.5% of flowActionEuronext Growth ParisISIN FR00105268142021DD741608Canonical exit: 15 Jul 2021 (T+90)
- 143,246 shares@ €1.503.9% of flowActionEuronext Growth ParisISIN FR00105268142021DD741432Canonical exit: 14 Jul 2021 (T+90)
12 of 12 declarations
About Supersonic Imagine
SuperSonic Imagine is a French medical technology company focused on ultrasound imaging. Founded in 2005 in Aix-en-Provence by Jacques Souquet, the company was built around a disruptive innovation: an ultrafast ultrasound platform capable of delivering real-time imaging with high definition and strong diagnostic precision. Its flagship technology, the Aixplorer® platform, was designed to improve non-invasive diagnosis and tissue characterization, with key use cases in radiology and in the assessment of breast, liver and prostate diseases, as well as broader general-imaging applications.
From the outset, SuperSonic Imagine differentiated itself in a market dominated by large global ultrasound manufacturers by focusing on image speed, image quality and advanced quantitative features, especially ShearWave™ elastography, which became one of the company’s signature technologies. In April 2014, the company listed its shares on Euronext Paris, a move that increased its visibility and strengthened its profile among investors and commercial partners.
Read moreShow less
The company subsequently expanded its industrial and international footprint, with commercial activity in more than 50 countries and more than 800 installed systems at the time of its IPO communication. Its strategy was centered on distributing cart-based ultrasound solutions to hospitals, imaging centers and specialists who rely on ultrasound as a first-line diagnostic or follow-up tool. SuperSonic Imagine’s market position has therefore been that of a technology-led niche specialist, combining a meaningful installed base, international reach and a differentiated product portfolio in medical ultrasound.
On the stock-market side, SuperSonic Imagine transferred its listing to Euronext Growth Paris effective 30 December 2020, while keeping the same ISIN code, FR0010526814. The company said the move was intended to better match its listing venue to its size, market capitalization and free float, while reducing certain listing obligations and costs. The company remained identified as a medtech specialist in ultrasound imaging.
A notable corporate event was Hologic’s 2019 announcement of a binding offer to acquire SuperSonic Imagine. Hologic, a US-based leader in women’s health and medical imaging, said the transaction would strengthen its breast-health portfolio through SuperSonic Imagine’s cart-based ultrasound technology. That interest highlights the strategic value of the company’s intellectual property and its reputation as an innovative French ultrasound specialist in a competitive medtech landscape.
